Can we predict pharmacokinetic profiles of drugs in humans from data of experimental animals?

DOI Web Site 6 References
  • Tsuji Akira
    Division of Pharmaceutical Sciences, Graduate School of Natural Science and Technology, Kanazawa University

Bibliographic Information

Other Title
  • 日本のトランスレーショナルリサーチをどう進めるか　　動物のデータはヒトにどこまで迫れるか？
  • 動物のデータはヒトにどこまで迫れるか?
  • ドウブツ ノ データ ワ ヒト ニ ドコ マデ セマレル カ

Search this article

Abstract

Understanding of the relationship of oral absorption and oral bioavailability (BA) of potential drug candidates between animals and humans is important in drug discovery and development. Despite the similarities in monkeys and humans, marked differences have been found in oral BA for many drugs. Because BA values determine the therapeutic potential of a drug, caution should be exercised in extrapolating data obtained in animals, especially in monkeys as it may not predict that in humans. There have been many improvements in predicting human pharmacokinetics, which are determined by functions of metabolic enzymes and transporters, based on a combination of animal, in vitro, and in silico (e.g., physiologically-based pharmacokinetic) models, but failures still occur.<BR> Microdosing studies in humans potentially have an important place in the drug development process inasmuch as they can offer an early determination of the pharmacokinetic properties of a compound and thus assist in the selection of those drug candidates that possess optimal disposition properties for further evaluation in the clinic. This strategy allows early evaluation of systemic clearance, oral bioavailability, and excretion ratio into urine as well as sources of intersubject variability and questions of specific metabolite formation.

Journal

  • Drug Delivery System

    Drug Delivery System 22 (1), 43-47, 2007

    THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM

References(6)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top